Logo image of ALSRS.PA

SIRIUS MEDIA (ALSRS.PA) Stock Fundamental Analysis

EPA:ALSRS - Euronext Paris - Matif - FR0010812230 - Common Stock - Currency: EUR

0.0028  +0 (+3.7%)

Fundamental Rating

0

Taking everything into account, ALSRS scores 0 out of 10 in our fundamental rating. ALSRS was compared to 62 industry peers in the Media industry. ALSRS may be in some trouble as it scores bad on both profitability and health. ALSRS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALSRS had negative earnings in the past year.
In the past year ALSRS had a positive cash flow from operations.
ALSRS had negative earnings in 4 of the past 5 years.
ALSRS had a positive operating cash flow in 4 of the past 5 years.
ALSRS.PA Yearly Net Income VS EBIT VS OCF VS FCFALSRS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

ALSRS has a worse Return On Assets (-4.96%) than 75.81% of its industry peers.
Industry RankSector Rank
ROA -4.96%
ROE N/A
ROIC N/A
ROA(3y)-3.7%
ROA(5y)-7.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSRS.PA Yearly ROA, ROE, ROICALSRS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

ALSRS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSRS.PA Yearly Profit, Operating, Gross MarginsALSRS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

ALSRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALSRS has been increased compared to 1 year ago.
ALSRS has more shares outstanding than it did 5 years ago.
ALSRS has a worse debt/assets ratio than last year.
ALSRS.PA Yearly Shares OutstandingALSRS.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ALSRS.PA Yearly Total Debt VS Total AssetsALSRS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -1.13, we must say that ALSRS is in the distress zone and has some risk of bankruptcy.
ALSRS's Altman-Z score of -1.13 is on the low side compared to the rest of the industry. ALSRS is outperformed by 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.13
ROIC/WACCN/A
WACC3.94%
ALSRS.PA Yearly LT Debt VS Equity VS FCFALSRS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

ALSRS has a Current Ratio of 0.21. This is a bad value and indicates that ALSRS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.21, ALSRS is doing worse than 91.94% of the companies in the same industry.
A Quick Ratio of 0.21 indicates that ALSRS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.21, ALSRS is doing worse than 91.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
ALSRS.PA Yearly Current Assets VS Current LiabilitesALSRS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALSRS have decreased strongly by -478.00% in the last year.
The Revenue for ALSRS has decreased by -61.40% in the past year. This is quite bad
ALSRS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.64% yearly.
EPS 1Y (TTM)-478%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.7%
Revenue 1Y (TTM)-61.4%
Revenue growth 3Y0.68%
Revenue growth 5Y-3.64%
Sales Q2Q%-97.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALSRS.PA Yearly Revenue VS EstimatesALSRS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ALSRS.PA Yearly EPS VS EstimatesALSRS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 -0.02 -0.04 -0.06 -0.08 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALSRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSRS.PA Price Earnings VS Forward Price EarningsALSRS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.37
ALSRS.PA Per share dataALSRS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIRIUS MEDIA

EPA:ALSRS (6/27/2025, 7:00:00 PM)

0.0028

+0 (+3.7%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap578.14K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF 0.16
P/B N/A
P/tB N/A
EV/EBITDA -0.37
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.02
OCFY620.09%
SpS0.03
BVpS-0.01
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.7%
ROA(5y)-7.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.88
Cap/Depr 103.2%
Cap/Sales 170.32%
Interest Coverage N/A
Cash Conversion 70.01%
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -1.13
F-Score2
WACC3.94%
ROIC/WACCN/A
Cap/Depr(3y)61.89%
Cap/Depr(5y)77.86%
Cap/Sales(3y)32.81%
Cap/Sales(5y)21.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-478%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.4%
Revenue growth 3Y0.68%
Revenue growth 5Y-3.64%
Sales Q2Q%-97.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-159%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-510.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y458.5%
OCF growth 3Y83.12%
OCF growth 5Y47.5%